DIALYSIS · CCN 392614

DaVita Abington

Willow Grove, PA 19090

DialysisProfitDaVita
$7.1M
TOTAL REVENUE
14.2%
OPERATING MARGIN
5 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.1M
Total costs
$6.1M
Operating income (rev − costs)
$1.0M
Operating margin
14.2%
Total charges
$7.1M
Total treatments
17,671
Dialysis stations
22

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.64137—
Fistula Rate
DFC_FISTULA_RATE
62.4114—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.3754—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
146.2158—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
1.12——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
13114—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
20.1568—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
36.9110—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.9127—
Standardized ED Visits Ratio
DFC_SEDR
0.3895—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
16.275—